furazolidone has been researched along with Candidiasis, Vulvovaginal in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GUIXA, HL | 1 |
| Stramezzi, P | 1 |
| Arbasino, M | 1 |
2 other studies available for furazolidone and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
[VULVOVAGINAL INFECTIONS IN CHILDHOOD].
Topics: Ammonium Compounds; Anti-Bacterial Agents; Antibiotics, Antitubercular; Arsenicals; Candidiasis, Vul | 1963 |
Four years of clinical investigations with nifuratel.
Topics: Antiprotozoal Agents; Antitrichomonal Agents; Candidiasis, Vulvovaginal; Female; Furazolidone; Human | 1969 |